You might be interested in
Health & Biotech
Health Check: Which biotech boards are at risk of a 'second strike'?
Health & Biotech
Health Check: Nuclear medicine stocks tipped to glow after favourable US decision
Health & Biotech
Stockhead TV
Stockhead’s Q-Wrapz video series features one-on-one interviews showcasing the latest quarterly results of emerging ASX companies.
In this instalment, former CNBC, Sky News, and Bloomberg news anchor Oriel Morrison interviews Alex Keach, managing director of ECS Botanics Holdings (ASX:ECS).
ECS Botanics is a vertically integrated and diversified cannabis company operating across the medical cannabis sub-sectors of hemp food and wellness, medicinal cannabis cultivation, GMP manufacturing and pharmaceutical supply.
The company made headlines in October following news it recorded a six-fold revenue increase in the wake of soaring demand for its sustainably grown cannabis.
To hear about the company’s quarterly highlights, standout areas and forward plan, click above.